MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Zoetis Inc

Fechado

SetorSaúde

163.53 1.1

Visão Geral

Variação de preço das ações

24h

Atual

Mín

160.7

Máximo

163.62

Indicadores-chave

By Trading Economics

Rendimento

-101M

581M

Vendas

-83M

2.3B

P/E

Médio do Setor

30.101

63.778

EPS

1.4

Rendimento de Dividendos

1.21

Margem de lucro

25.076

Funcionários

13,800

EBITDA

-133M

906M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+28.29% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

1.21%

2.39%

Próximos Ganhos

6 de mai. de 2025

Próxima data de ex-dividendo

21 de abr. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-5.1B

74B

Abertura anterior

162.43

Fecho anterior

163.53

Sentimento de Notícias

By Acuity

29%

71%

87 / 386 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Zoetis Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

4 de nov. de 2024, 12:47 UTC

Ganhos

Zoetis Lifts Guidance On Strong Demand as 3Q Beats Market Views

6 de ago. de 2024, 11:52 UTC

Ganhos

Zoetis Raises Guidance After 2Q Sales, Earnings Rise

20 de fev. de 2025, 08:00 UTC

Principais Notícias

A Bird-Flu Vaccine Could Bring Down Egg Prices. Why the Poultry Industry Is Fighting It. -- Barrons.com

13 de fev. de 2025, 13:47 UTC

Ganhos

Zoetis Plunges 9% As 2025 Guidance Misses Expectations -- IBD

13 de fev. de 2025, 12:09 UTC

Ganhos

Zoetis Sees FY25 Adj EPS $6-Adj EPS $6.10 >ZTS

13 de fev. de 2025, 12:08 UTC

Ganhos

Zoetis Sees FY25 Rev $9.225B-$9.375B >ZTS

13 de fev. de 2025, 12:08 UTC

Ganhos

Zoetis Sees FY25 EPS $5.70-EPS $5.80 >ZTS

13 de fev. de 2025, 12:00 UTC

Ganhos

Zoetis 4Q EPS $1.29 >ZTS

13 de fev. de 2025, 12:00 UTC

Ganhos

Zoetis 4Q Rev $2.32B >ZTS

13 de fev. de 2025, 12:00 UTC

Ganhos

Zoetis 4Q Net $581M >ZTS

4 de nov. de 2024, 14:05 UTC

Ganhos

Zoetis Barks Up A Third-Quarter Beat And Raise, But Stock Slips -- IBD

4 de nov. de 2024, 12:06 UTC

Ganhos

Zoetis Sees 2024 Rev $9.2B-$9.3B >ZTS

4 de nov. de 2024, 12:06 UTC

Ganhos

Zoetis Sees 2024 Adj EPS $5.86-Adj EPS $5.92 >ZTS

4 de nov. de 2024, 12:05 UTC

Ganhos

Zoetis 3Q Adj EPS $1.58 >ZTS

4 de nov. de 2024, 12:00 UTC

Ganhos

Zoetis 3Q Net $682M >ZTS

4 de nov. de 2024, 12:00 UTC

Ganhos

Zoetis 3Q EPS $1.50 >ZTS

4 de nov. de 2024, 12:00 UTC

Ganhos

Zoetis 3Q Rev $2.39B >ZTS

6 de ago. de 2024, 11:44 UTC

Ganhos

Zoetis Earnings Growth Picks Up, Tops Views -- IBD

6 de ago. de 2024, 11:09 UTC

Ganhos

Zoetis Raises 2024 Operational Revenue Growth View to 9%-11% >ZTS

6 de ago. de 2024, 11:08 UTC

Ganhos

Zoetis Raises 2024 View To Adj EPS $5.78-Adj EPS $5.88 >ZTS

6 de ago. de 2024, 11:08 UTC

Ganhos

Zoetis Raises 2024 View To Rev $9.1B-$9.25B >ZTS

6 de ago. de 2024, 11:08 UTC

Ganhos

Zoetis 2Q Adj EPS $1.56 >ZTS

6 de ago. de 2024, 11:00 UTC

Ganhos

Zoetis 2Q Net $624M >ZTS

6 de ago. de 2024, 11:00 UTC

Ganhos

Zoetis 2Q Rev $2.36B >ZTS

6 de ago. de 2024, 11:00 UTC

Ganhos

Zoetis 2Q EPS $1.37 >ZTS

2 de mai. de 2024, 17:43 UTC

Ganhos

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2 de mai. de 2024, 13:06 UTC

Ganhos

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2 de mai. de 2024, 11:27 UTC

Ganhos

Zoetis Earnings Top; Pet Drugmaker Rises -- IBD

2 de mai. de 2024, 11:00 UTC

Ganhos

Zoetis 1Q Net $599M >ZTS

2 de mai. de 2024, 11:00 UTC

Ganhos

Zoetis 1Q EPS $1.31 >ZTS

Comparação entre Pares

Variação de preço

Zoetis Inc Previsão

Preço-alvo

By TipRanks

28.29% parte superior

Previsão para 12 meses

Média 207.71 USD  28.29%

Máximo 242 USD

Mínimo 180 USD

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para Zoetis Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

8 ratings

7

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

161.695 / 163.24Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Strong Bearish Evidence

Sentimento

By Acuity

87 / 386 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.